Cure Kids Ventures
VC Fund
Auckland, New Zealand
Cure Kids Ventures is a VC fund in Auckland focused on Medical Device and Health Care. Cure Kids Ventures is wholly owned subsidiary of cure kidsIts investment focus is on research, seed, early stage and expansion ventures with high growth potential and with products capable of improving health outcomes, particularly for children.A wide range of potential products can be considered for investment by Cure Kids Ventures Ltd.These include medical devices, therapeutic medicines, nutraceuticals and software products.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Cure Kids Ventures invests in
Stages Cure Kids Ventures invests in
Countries Cure Kids Ventures invests in
Round sizes
Round size
- Seed
- $999k–$9.7M
Investment Focus
Industry
- Medical Device 6 (40%)
- Health Care 5 (33%)
- Manufacturing 4 (27%)
- Biotechnology 3 (20%)
- SaaS 2 (13%)
Stage
- Seed 10 (67%)
- Series A 2 (13%)
- Pre-Seed 1 (7%)
- Venture - Series Unknown 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care. | $4.3M / Seed / Feb 10, 2026 | ||
| ISpy Nits manufacturer develops a biofluorescent powder for treating lice and nits. The company's product kit includes lotion and a non-toxic glow powder that binds to the egg sheath to intensify the effect. As the chemicals interact with bioluminescent proteins, they emit light that is visible to the human eye, identifying lice and their eggsand removing them. | Seed / Dec 01, 2023 | ||
| Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices. | Seed / Sep 13, 2023 | ||
| Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care. | $1.7M / Seed / Jun 01, 2023 | ||
| Formus is enabling personalized orthopedics at scale through a fusion of AI-automation with computational biomechanics. Built on 20 years of musculoskeletal research at the Auckland Bioengineering Institute, Formus 3D pre-op planning is FDA, PMDA, and TGA cleared, and has planned over 3,000 hip replacement surgeries at more than 25 sites acrossANZ, Japan, and the US. We are at the next frontier of orthopedics, combining AI-automation with patient-specific modelling of bony and soft-tissue to optimize joint replacement surgeries for each and every patient. Working in tandem with implant manufacturers, we integrate seamlessly into existing industry workflows to reduce costs and vastly increase reliability and scalability. Formus's unique capabilities empower surgeons to revolutionize personalized orthopedics at scale to improve the outcomes of every patient. | $2.3M / Seed / Mar 01, 2023 | ||
| Kitea Health creates pressure monitoring implantable medical devices. | $3.7M / Seed / Feb 23, 2023 | ||
| The data-driven wellbeing platform that empowers students and enables schools to make positive and effective interventions. | Seed / Dec 20, 2022 | ||
| chnnl is an app that provides information and data on employee's mental health and wellbeing. | Venture - Series Unknown / Mar 03, 2022 | ||
| RespirAq is a medical equipment manufacturing company that offers heated humidifier performance in an HME size and reliability. | $999.1K / Seed / Jan 26, 2022 | ||
| Amaroq Therapeutics is a biotechnology company that focuses on the development of next-generation cancer therapies. The company's research is centered around long non-coding RNAs, often referred to as the 'dark matter' of the human genome. These molecules, which were only recently discovered, are being explored for their potential incancer treatment. Amaroq Therapeutics is developing novel cancer therapies that specifically target these long non-coding RNAs. The company's work is based on research spun out of the University of Otago in Dunedin, New Zealand. | $9.7M / Seed / Jul 08, 2021 | ||
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Cure Kids Ventures invest in?
Cure Kids Ventures invests primarily in Medical Device, Health Care and Manufacturing startups, most often at Seed and Series A stage. Most of the 15 investments tracked by Shizune back companies in New Zealand. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Cure Kids Ventures invest in?
Cure Kids Ventures typically joins rounds of $999k–$9.7M at Seed. These are whole funding-round sizes, not Cure Kids Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Cure Kids Ventures took part in.
When did Cure Kids Ventures last invest?
The most recent investment recorded for Cure Kids Ventures closed in Feb 2026. Shizune tracks 15 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
